Web Analytics

3 Latest Announced Rounds

  • $45,000,000
    Series A

    5 Investors

    Biotechnology Research
    Sep 18th, 2025
  • $10,000,000
    Seed

    4 Investors

    Biotechnology Research
    Sep 18th, 2025
  • $5,000,000
    Seed

    1 Investors

    Financial Services
    Sep 18th, 2025
$1,753.82M Raised in 62 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Georgiamune Inc.

start up
United States - Gaithersburg, Maryland
  • 10/08/2023
  • Series A
  • $75,000,000

Georgiamune Inc. is a private, science and discovery clinical stage immunotherapeutic biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases. Unique approaches to re-establishing immune balance and groundbreaking scientific discoveries have led to the development of pioneering immune therapeutics for cancer and autoimmune diseases.


Related People